95977-29-0

Basic information

• Product Name: Haloxyfop-P
• Synonyms: (R)-2-[4-[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propanoic acid;Haloxyfop-P;Haloxyfop-p [iso];Haloxyfop-P (free acid);(R)-2-[4-(3-Chloro-5-(trifluoromethyl)-2-pyridyloxy)phenoxy]propionic acid;(R)-2-(4-((3-Chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)phenoxy)propanoic acid;haloxyfop-P Solution, 1000ppm;haloxyfop-P Solution, 100ppm
• CAS NO: 95977-29-0
• Molecular Formula: C₁₅H₁₁ClF₃NO₄
• Molecular Weight: 361.7
• Mol File: 95977-29-0.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 420.3 °C at 760 mmHg
• Flash Point: 208 °C
• Appearance: /
• Density: 1.442
• Vapor Pressure: 8.17E-08mmHg at 25°C
• Refractive Index: 1.535
• Solubility: Dichloromethane; Ethyl Acetate; Ether
• PKA: 3.12±0.10(Predicted)
• BRN: 8571970
• CAS DataBase Reference: Haloxyfop-P(CAS DataBase Reference)
• NIST Chemistry Reference: Haloxyfop-P(95977-29-0)
• EPA Substance Registry System: Haloxyfop-P(95977-29-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22-52/53
• WGK Germany: 3
• Hazardous Substances Data: 95977-29-0(Hazardous Substances Data)

Usage

Uses

Haloxyfop-P is a herbicide for controlling weeds in cassia fields. A pesticide residue in vegetables.

InChI:InChI=1/C15H11ClF3NO4/c1-8(14(21)22)23-10-2-4-11(5-3-10)24-13-12(16)6-9(7-20-13)15(17,18)19/h2-8H,1H3,(H,21,22)/t8-/m1/s1

Upstream product

• 69045-89-2 2-(4'-hydroxyphenoxy)-3-chloro-5-trifluoromethylpyridine 
• 29617-66-1 (S)-2-chloropropanoic acid 
• 73246-45-4 methyl-(S)-2-chloropropionate 
• 94050-90-5 (RS)-2-(4-hydroxyphenoxy)propionic acid 
• 69045-84-7 2,3-dichloro-5-trifluoromethylpyridine 
• 72619-32-0 (R)-2-[4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propanoic acid methyl ester 
• 94050-90-5 (R)-2-(4-hydroxyphenoxy)propionic acid 
• 69806-34-4 haloxyfop 

Relevant articles and documents

Structure, activity, and inhibition of the carboxyltransferase β-Subunit of acetyl coenzyme a carboxylase (AccD6) from mycobacterium tuberculosis

In Mycobacterium tuberculosis, the carboxylation of acetyl coenzyme A (acetyl-CoA) to produce malonyl-CoA, a building block in long-chain fatty acid biosynthesis, is catalyzed by two enzymes working sequentially: a biotin carboxylase (AccA) and a carboxyl

Aryloxy-phenoxy alkane acid derivative and medicinal application thereof

The invention discloses an aryloxy-phenoxy alkane acid derivative and a medicinal application thereof. The aryloxy-phenoxy alkane acid derivative is shown as the chemical formula I in the specification, wherein R1 is any one of hydrogen, alkyl containing

Evaluation of the Edman degradation product of vancomycin bonded to core-shell particles as a new HPLC chiral stationary phase

A modified macrocyclic glycopeptide-based chiral stationary phase (CSP), prepared via Edman degradation of vancomycin, was evaluated as a chiral selector for the first time. Its applicability was compared with other macrocyclic glycopeptide-based CSPs: TeicoShell and VancoShell. In addition, another modified macrocyclic glycopeptide-based CSP, NicoShell, was further examined. Initial evaluation was focused on the complementary behavior with these glycopeptides. A screening procedure was used based on previous work for the enantiomeric separation of 50 chiral compounds including amino acids, pesticides, stimulants, and a variety of pharmaceuticals. Fast and efficient chiral separations resulted by using superficially porous (core-shell) particle supports. Overall, the vancomycin Edman degradation product (EDP) resembled TeicoShell with high enantioselectivity for acidic compounds in the polar ionic mode. The simultaneous enantiomeric separation of 5 racemic profens using liquid chromatography-mass spectrometry with EDP was performed in approximately 3?minutes. Other highlights include simultaneous liquid chromatography separations of rac-amphetamine and rac-methamphetamine with VancoShell, rac-pseudoephedrine and rac-ephedrine with NicoShell, and rac-dichlorprop and rac-haloxyfop with TeicoShell.